Evaluation of candidate diagnostic MicroRNAs in thyroid fine-needle aspiration biopsy samples

Thyroid

Volumn 22, Issue 3, 2012, Pages 285-291

  Kitano, Mio ^a   Rahbari, Reza ^a   Patterson, Erin E ^a   Steinberg, Seth M ^a   Prasad, Nijaguna B ^b   Wang, Yongchun ^b   Zeiger, Martha A ^b   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MIR 126; MIR 374A; MIR 7; MIR LET7G; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE;

EID: 84863291723     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0313     Document Type: Article

References (42)

1. Sipos JA, Mazzaferri EL 2010 Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 22:395-404.
2. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998 A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]. Cancer 83:2638-2648.
3. Clark OH 1996 Predictors of thyroid tumor aggressiveness. West J Med 165:131-138.
4. Dean DS, Gharib H 2008 Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22:901-911.
5. Amrikachi M, Ramzy I, Rubenfeld S, Wheeler TM 2001 Accuracy of fine-needle aspiration of thyroid. Arch Pathol Lab Med 125:484-488.
6. Yang J, Schnadig V, Logrono R, Wasserman PG 2007 Fineneedle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations. Cancer 111:306-315.
7. Wang CC, Friedman L, Kennedy GC, Wang H, Kebebew E, Steward DL, Zeiger MA,WestraWH, Wang Y, Khanafshar E, Fellegara G, Rosai J, Livolsi V, Lanman RB 2010 A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid 21:243-251.
8. Faquin WC, Baloch ZW 2010 Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol 38:731-739.
9. Davidov T, Trooskin SZ, Shanker BA, Yip D, Eng O, Crystal J, Hu J, Chernyavsky VS, Deen MF, May M, Artymyshyn RL 2010 Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy. Surgery 148:1294-1299; discussion 9-301.
10. Oertel YC, Miyahara-Felipe L, Mendoza MG, Yu K 2007 Value of repeated fine needle aspirations of the thyroid: An analysis of over ten thousand FNAs. Thyroid 17:1061-1066.
11. Tan YY, Kebebew E, Reiff E, Caron NR, Ogilvie JB, Duh QY, Clark OH, Ljung BM, Miller T 2007 Does routine consultation of thyroid fine-needle aspiration cytology change surgical management? J Am Coll Surg 205:8-12.
12. Shibru D, Chung KW, Kebebew E 2008 Recent developments in the clinical application of thyroid cancer biomarkers. Curr Opin Oncol 20:13-18.
13. Banks ND, Kowalski J, Tsai HL, Somervell H, Tufano R, Dackiw AP, Marohn MR, Clark DP, Umbricht CB, Zeiger MA 2008 A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 18:933-941.
14. Chudova D, Wilde JI, Wang ET, Wang H, Rabbee N, Egidio CM, Reynolds J, Tom E, Pagan M, Rigl CT, Friedman L, Wang CC, Lanman RB, Zeiger M, Kebebew E, Rosai J, Fellegara G, Livolsi VA, Kennedy GC 2010 Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab 95:5296-5304.
15. Kouniavsky G, Zeiger MA 2010 Thyroid tumorigenesis and molecular markers in thyroid cancer. Curr Opin Oncol 22:23-29.
16. Vriens MR, Schreinemakers JM, Suh I, Guerrero MA, Clark OH 2009 Diagnostic markers and prognostic factors in thyroid cancer. Future Oncol 5:1283-1293.
17. Stang MT, Carty SE 2009 Recent developments in predicting thyroid malignancy. Curr Opin Oncol 21:11-17.
18. Chiu CG, Strugnell SS, Griffith OL, Jones SJ, Gown AM, Walker B, Nabi IR, Wiseman SM 2010 Diagnostic utility of galectin-3 in thyroid cancer. Am J Pathol 176:2067-2081.
19. Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC 2011 Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: A prospective study. Thyroid 21:717-723.
20. Ambros V 2004 The functions of animal microRNAs. Nature 431:350-355.
21. Esquela-Kerscher A, Slack FJ 2006 Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259-269.
22. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE 2008 MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility. J Clin Endocrinol Metab 93:1600-1608.
23. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A 2005 The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102:19075-19080.
24. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A 2006 MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13:497-508.
25. Tetzlaff MT, Liu A, Xu X, Master SR, Baldwin DA, Tobias JW, Livolsi VA, Baloch ZW 2007 Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18:163-173.
26. Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T 2008 MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 21:1139-1146.
27. Mazeh H, Mizrahi I, Halle D, Ilyayev N, Stojadinovic A, Trink B, Mitrani-Rosenbaum S, Roistacher M, Ariel I, Eid A, Freund HR, Nissan A 2011 Development of a micro-RNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Thyroid 21:111-118.
28. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C 2006 A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 91:3584-3591.
29. Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker-Preuss M, Schmid KW 2010 Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 102:376-382.
30. Ricarte-Filho JC, Fuziwara CS, Yamashita AS, Rezende E, da-Silva MJ, Kimura ET 2009 Effects of let-7 microRNA on cell growth and differentiation of papillary thyroid cancer. Transl Oncol 2:236-241.
31. Chou CK, Chen RF, Chou FF, Chang HW, Chen YJ, Lee YF, Yang KD, Cheng JT, Huang CC, Liu RT 2010 miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation. Thyroid 20:489-494.
32. Kitano M, Rahbari R, Patterson EE, Xiong Y, Prasad NB, Wang Y, Zeiger MA, Kebebew E 2011 Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Ann Surg Oncol 18:3443-3452.
33. Hamberger B, Gharib H, Melton LJ 3rd, Goellner JR, Zinsmeister AR 1982 Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med 73:381-384.
34. Castro MR, Gharib H 2003 Thyroid fine-needle aspiration biopsy: Progress, practice, and pitfalls. Endocr Pract 9:128-136.
35. Hadi M, Gharib H, Goellner JR, Heerden JA 1997 Has fineneedle aspiration biopsy changed thyroid practice? Endocr Pract 3:9-13.
36. Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, Kolokythas A, Wang A, Dai Y, Zhou X 2010 MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 432:199-205.
37. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, Purow B 2008 microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68:3566-3572.
38. Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, Chen HC, Yeh SD, Wu CW 2010 EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res 70:8822-8831.
39. Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW, Klijn JG, Wiemer EA, Martens JW 2008 Four miRNAs associated with aggressiveness of lymph nodenegative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 105:13021-13026.
40. Duex JE, Comeau L, Sorkin A, Purow B, Kefas B 2011 USP18 regulates EGF receptor expression and cancer cell survival via microRNA-7. J Biol Chem 286:25377-25386.
41. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ 2009 Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 284:5731-5741.
42. Reddy SD, Ohshiro K, Rayala SK, Kumar R 2008 Micro-RNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 68:8195-8200.